Cargando…
Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
Coronavirus disease (COVID-19) pandemic has been a global disease burden. It has affected more than sixteen million people in the world within seven months of its first outbreak in Wuhan. Different treatment modalities, therapeutic and prophylactic agents for its therapy are underway. Until the prov...
Autores principales: | Khadka, Sitaram, Shrestha, Dhan Bahadur, Budhathoki, Pravash, Rawal, Era |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450277/ https://www.ncbi.nlm.nih.gov/pubmed/32904117 http://dx.doi.org/10.2147/CPAA.S269156 |
Ejemplares similares
-
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
por: Budhathoki, Pravash, et al.
Publicado: (2020) -
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis()
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021) -
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2020) -
Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries
por: Adhikari, Sugat, et al.
Publicado: (2020) -
Repeat Cesarean Section among Pregnant Women in a Tertiary Center of Nepal: A Descriptive Cross-sectional Study
por: Regmi, Dharma Raj, et al.
Publicado: (2022)